SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 50 filers reported holding SINOVAC BIOTECH LTD in Q2 2014. The put-call ratio across all filers is 4.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,600,000 | +24.6% | 305,900 | +14.6% | 0.01% | +16.7% |
Q3 2014 | $1,284,000 | -62.6% | 266,900 | -56.2% | 0.01% | -62.5% |
Q2 2014 | $3,435,000 | -2.2% | 609,100 | +24.8% | 0.02% | -11.1% |
Q1 2014 | $3,514,000 | +26.5% | 488,100 | +7.5% | 0.02% | +28.6% |
Q4 2013 | $2,778,000 | – | 453,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |